Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model

An estimated 10 million people developed tuberculosis (TB) disease in 2019 which underscores the need for a vaccine that prevents disease and reduces transmission. The aim of our current studies is to characterize and test a prophylactic tuberculosis vaccine comprised of ID93, a polyprotein fusion a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldwin, Susan L., Reese, Valerie A., Larsen, Sasha E., Beebe, Elyse, Guderian, Jeff, Orr, Mark T., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951850/
https://www.ncbi.nlm.nih.gov/pubmed/33705411
http://dx.doi.org/10.1371/journal.pone.0247990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951850/
https://www.ncbi.nlm.nih.gov/pubmed/33705411
http://dx.doi.org/10.1371/journal.pone.0247990

Ejemplares similares